These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B. Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911 [TBL] [Abstract][Full Text] [Related]
23. Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study. Sheng WH; Hung CC; Kao JH; Chang SY; Chen MY; Hsieh SM; Chen PJ; Chang SC Clin Infect Dis; 2007 Apr; 44(7):988-95. PubMed ID: 17342655 [TBL] [Abstract][Full Text] [Related]
24. A practical guide to the use of interferons in the management of hepatitis virus infections. Saracco G; Rizzetto M Drugs; 1997 Jan; 53(1):74-85. PubMed ID: 9010649 [TBL] [Abstract][Full Text] [Related]
31. Therapeutic efficacy of sequential and simultaneous treatments with interferon-alpha and lamivudine in children with chronic hepatitis B. Akman SA; Okcu SC; Halicioğlu O; Sutcuoglu S; Anil M; Kizilgunesler A; Bakiler AR Pediatr Int; 2007 Dec; 49(6):848-52. PubMed ID: 18045284 [TBL] [Abstract][Full Text] [Related]
32. A randomized, controlled study of thymosin-alpha1 therapy in patients with anti-HBe, HBV-DNA-positive chronic hepatitis B. Zavaglia C; Severini R; Tinelli C; Franzone JS; Airoldi A; Tempini S; Bettale G; Ideo G Dig Dis Sci; 2000 Apr; 45(4):690-6. PubMed ID: 10759236 [TBL] [Abstract][Full Text] [Related]
33. Lamivudine and alpha-interferon in combination long term for precore mutant chronic hepatitis B. Tatulli I; Francavilla R; Rizzo GL; Vinciguerra V; Ierardi E; Amoruso A; Panella C; Francavilla A J Hepatol; 2001 Dec; 35(6):805-10. PubMed ID: 11738109 [TBL] [Abstract][Full Text] [Related]
34. Resolution of chronic hepatitis Delta after 1 year of combined therapy with pegylated interferon, tenofovir and emtricitabine. Mansour W; Ducancelle A; Le Gal F; Le Guillou-Guillemette H; Abgueguen P; Pivert A; Calès P; Gordien E; Lunel F J Clin Virol; 2010 Jan; 47(1):97-9. PubMed ID: 19914127 [TBL] [Abstract][Full Text] [Related]
35. Individualization of interferon therapy using serum hepatitis B virus DNA to reduce viral relapse in patients with chronic hepatitis B: a randomized controlled trial. Chung YH; Song BC; Lee GC; Shin JW; Ryu SH; Jung SA; Yoo K; Lee HC; Lee YS; Suh DJ Eur J Gastroenterol Hepatol; 2003 May; 15(5):489-93. PubMed ID: 12702905 [TBL] [Abstract][Full Text] [Related]
36. Hepatitis D virus-specific cytokine responses in patients with chronic hepatitis delta before and during interferon alfa-treatment. Grabowski J; Yurdaydìn C; Zachou K; Buggisch P; Hofmann WP; Jaroszewicz J; Schlaphoff V; Manns MP; Cornberg M; Wedemeyer H; Liver Int; 2011 Oct; 31(9):1395-405. PubMed ID: 21762356 [TBL] [Abstract][Full Text] [Related]
37. Lamivudine treatment for chronic hepatitis B infection in children unresponsive to interferon. Hartman C; Berkowitz D; Shouval D; Eshach-Adiv O; Hino B; Rimon N; Satinger I; Kra-Oz T; Daudi N; Shamir R Pediatr Infect Dis J; 2003 Mar; 22(3):224-9. PubMed ID: 12634582 [TBL] [Abstract][Full Text] [Related]
38. Effectiveness of lamivudine and interferon-alpha combination therapy versus interferon-alpha monotherapy for the treatment of HBeAg-negative chronic hepatitis B patients: a randomized clinical trial. Karabay O; Tamer A; Tahtaci M; Vardi S; Celebi H J Microbiol Immunol Infect; 2005 Aug; 38(4):262-6. PubMed ID: 16118673 [TBL] [Abstract][Full Text] [Related]
39. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients? Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903 [TBL] [Abstract][Full Text] [Related]
40. A three-month course of lamivudine therapy in HBeAg-positive hepatitis B patients with normal aminotransferase levels. Yalçin K; Değertekin H; Kokoğlu OF; Ayaz C Turk J Gastroenterol; 2004 Mar; 15(1):14-20. PubMed ID: 15264116 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]